Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Sharps Technology, Inc. ( (STSS) ) has shared an announcement.
Sharps Technology, a leader in smart safety syringe solutions, announced plans to expand its Hungary manufacturing facility to meet growing demand, following a $50+ million sales agreement with a U.S. pharma company. This expansion aims to boost production of its SecureGard and SoloGard syringes, projecting significant revenue growth, with deliveries starting in Q1 2025. The company is also exploring collaborations with Hungarian investment opportunities to further expand its manufacturing capabilities.
For a thorough assessment of STSS stock, go to TipRanks’ Stock Analysis page.
Trending Articles
- Oppenheimer Pounds the Table on Coinbase Stock
- New “Anti-Woke” ETF Targets Starbucks (NASDAQ:SBUX)
- Ford (NYSE:F) Plans New EV Plant
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
